Cargando…

Progression of motor subtypes in Huntington’s disease: a 6-year follow-up study

The objective of this study is to investigate the progression of predominantly choreatic and hypokinetic-rigid signs in Huntington’s disease (HD) and their relationship with cognitive and general functioning over time. The motor signs in HD can be divided into predominantly choreatic and hypokinetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, M., Hart, E. P., van Zwet, E. W., Bentivoglio, A. R., Burgunder, J. M., Craufurd, D., Reilmann, R., Saft, C., Roos, R. A. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037142/ https://www.ncbi.nlm.nih.gov/pubmed/27435968 http://dx.doi.org/10.1007/s00415-016-8233-x

Ejemplares similares

Functional and cognitive capacity differ in dystonic motor subtypes when compared to choreatic and hypokinetic‐rigid motor subtypes in Huntington's disease
por: Achenbach, Jannis, et al.
Publicado: (2020)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression
por: Hare, Emily, et al.
Publicado: (2022)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Does arterial hypertension influence the onset of Huntington's disease?
por: Valcárcel-Ocete, Leire, et al.
Publicado: (2018)

Translational research in Huntington’s disease: opening up for disease modifying treatment
por: Burgunder, Jean-Marc
Publicado: (2013)

NMDA receptor gene variations as modifiers in Huntington disease: a replication study
por: Saft, Carsten, et al.
Publicado: (2011)

Atrophy of the putamen at time of clinical motor onset in Huntington’s disease: a 6-year follow-up study
por: Coppen, Emma M., et al.
Publicado: (2018)

The Impact of Upcoming Treatments in Huntington’s Disease: Resource Capacity Limitations and Access to Care Implications
por: Guttman, Mark, et al.
Publicado: (2021)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease
por: Hart, Ellen, et al.
Publicado: (2011)

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study
por: Baake, Verena, et al.
Publicado: (2018)

Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington’s Disease
por: Achenbach, Jannis, et al.
Publicado: (2022)

Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
por: Reilmann, Ralf
Publicado: (2013)

Corrigendum: Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Cognitive decline in Huntington’s disease in the Digitalized Arithmetic Task (DAT)
por: Lunven, Marine, et al.
Publicado: (2021)

Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

The Role of the Immune System in Huntington's Disease
por: Ellrichmann, Gisa, et al.
Publicado: (2013)

The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients
por: Metzger, Silke, et al.
Publicado: (2013)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Error Processing in Huntington's Disease
por: Beste, Christian, et al.
Publicado: (2006)

Neuropsychiatry and White Matter Microstructure in Huntington’s Disease
por: Gregory, Sarah, et al.
Publicado: (2015)

Obsessive-Compulsive and Perseverative Behaviors in Huntington’s Disease
por: Oosterloo, Mayke, et al.
Publicado: (2019)

White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

Positive effect of immunomodulatory therapies on disease progression in Huntington’s disease? Data from a real-world cohort
por: Achenbach, Jannis, et al.
Publicado: (2022)

Huntington's like conditions in China, A review of published Chinese cases
por: Zheng, Zhenzhen, et al.
Publicado: (2012)

Oral and dental health in Huntington‘s disease - an observational study
por: Saft, Carsten, et al.
Publicado: (2013)

Progressive microstructural changes of the occipital cortex in Huntington’s disease
por: Odish, Omar F. F., et al.
Publicado: (2018)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

Music perception and movement deterioration in Huntington’s disease
por: Beste, Christian, et al.
Publicado: (2011)

A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington’s disease
por: Lunven, Marine, et al.
Publicado: (2023)

DNA methylation study of Huntington’s disease and motor progression in patients and in animal models
por: Lu, Ake T., et al.
Publicado: (2020)

Objectively characterizing Huntington’s disease using a novel upper limb dexterity test
por: Woodgate, Samuel, et al.
Publicado: (2021)

Differential diagnosis of chorea (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling
por: Minkova, Lora, et al.
Publicado: (2015)

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease
por: Minkova, Lora, et al.
Publicado: (2017)

Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington’s Disease
por: Wiest, Roland, et al.
Publicado: (2017)

Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease
por: McLauchlan, Duncan James, et al.
Publicado: (2022)

Irritability in pre-clinical Huntington's disease
por: Klöppel, Stefan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7colmcd4gf0n4iqg4ivis3sqt9